161 related articles for article (PubMed ID: 20560773)
21. Resistance-induced changes in triclabendazole transport in Fasciola hepatica: ivermectin reversal effect.
Mottier L; Alvarez L; Fairweather I; Lanusse C
J Parasitol; 2006 Dec; 92(6):1355-60. PubMed ID: 17304820
[TBL] [Abstract][Full Text] [Related]
22. Liquid chromatography/mass spectrometric identification of benzimidazole anthelminthics metabolites formed ex vivo by Dicrocoelium dendriticum.
Cvilink V; Szotáková B; Vokrál I; Bártíková H; Lamka J; Skálová L
Rapid Commun Mass Spectrom; 2009 Sep; 23(17):2679-84. PubMed ID: 19630029
[TBL] [Abstract][Full Text] [Related]
23. Interaction of Fasciola hepatica with albendazole and its metabolites.
Fetterer RH; Rew RS
J Vet Pharmacol Ther; 1984 Jun; 7(2):113-8. PubMed ID: 6431118
[TBL] [Abstract][Full Text] [Related]
24. Time dependent pharmacokinetics of albendazole in human.
Mirfazaelian A; Rouini MR; Dadashzadeh S
Biopharm Drug Dispos; 2003 Jul; 24(5):199-204. PubMed ID: 12784319
[TBL] [Abstract][Full Text] [Related]
25. Comparative sulphoxidation of albendazole by sheep and cattle liver microsomes and the inhibitory effect of methimazole.
Lanusse CE; Nare B; Prichard RK
Xenobiotica; 1993 Mar; 23(3):285-95. PubMed ID: 8498091
[TBL] [Abstract][Full Text] [Related]
26. Antitumor activity of albendazole against the human colorectal cancer cell line HT-29: in vitro and in a xenograft model of peritoneal carcinomatosis.
Pourgholami MH; Akhter J; Wang L; Lu Y; Morris DL
Cancer Chemother Pharmacol; 2005 May; 55(5):425-32. PubMed ID: 15565325
[TBL] [Abstract][Full Text] [Related]
27. Comparative metabolism of albendazole and albendazole sulphoxide by different helminth parasites.
Solana HD; Rodriguez JA; Lanusse CE
Parasitol Res; 2001 Apr; 87(4):275-80. PubMed ID: 11355675
[TBL] [Abstract][Full Text] [Related]
28. Comparative enantioselectivity in the sulphoxidation of albendazole in man, dogs and rats.
Delatour P; Benoit E; Besse S; Boukraa A
Xenobiotica; 1991 Feb; 21(2):217-21. PubMed ID: 2058177
[TBL] [Abstract][Full Text] [Related]
29. Evaluation of the interaction between ivermectin and albendazole following their combined use in lambs.
Alvarez L; Lifschitz A; Entrocasso C; Manazza J; Mottier L; Borda B; Virkel G; Lanusse C
J Vet Pharmacol Ther; 2008 Jun; 31(3):230-9. PubMed ID: 18471144
[TBL] [Abstract][Full Text] [Related]
30. Metabolism of drugs and other xenobiotics in giant liver fluke (Fascioloides magna).
Prchal L; Vokřál I; Kašný M; Rejšková L; Zajíčková M; Lamka J; Skálová L; Lecová L; Szotáková B
Xenobiotica; 2016; 46(2):132-40. PubMed ID: 26153440
[TBL] [Abstract][Full Text] [Related]
31. Developmental toxicity of albendazole and its three main metabolites in zebrafish embryos.
Carlsson G; Patring J; Ullerås E; Oskarsson A
Reprod Toxicol; 2011 Jul; 32(1):129-37. PubMed ID: 21683134
[TBL] [Abstract][Full Text] [Related]
32. Reversed-phase liquid chromatographic method with fluorescence detection for the simultaneous determination of albendazole sulphoxide, albendazole sulphone and albendazole 2-aminosulphone in sheep plasma.
Batzias GC; Delis GA
J Chromatogr B Analyt Technol Biomed Life Sci; 2004 Jun; 805(2):267-74. PubMed ID: 15135100
[TBL] [Abstract][Full Text] [Related]
33. Sulphoxidation of albendazole by the FAD-containing and cytochrome P-450 dependent mono-oxygenases from pig liver microsomes.
el Amri HS; Fargetton X; Delatour P; Batt AM
Xenobiotica; 1987 Oct; 17(10):1159-68. PubMed ID: 3424864
[TBL] [Abstract][Full Text] [Related]
34. The Effect of Protein Restriction in the In Vitro Metabolism of Albendazole in Rats.
Belaz KR; de O Cardoso J; da Silva CA; Oliveira RV
Drug Metab Lett; 2015; 9(1):8-16. PubMed ID: 25827239
[TBL] [Abstract][Full Text] [Related]
35. Comparative hepatic and extrahepatic enantioselective sulfoxidation of albendazole and fenbendazole in sheep and cattle.
Virkel G; Lifschitz A; Sallovitz J; Pis A; Lanusse C
Drug Metab Dispos; 2004 May; 32(5):536-44. PubMed ID: 15100176
[TBL] [Abstract][Full Text] [Related]
36. Chiral behaviour of the metabolite albendazole sulphoxide in sheep, goats and cattle.
Delatour P; Garnier F; Benoit E; Caude I
Res Vet Sci; 1991 Mar; 50(2):134-8. PubMed ID: 2034891
[TBL] [Abstract][Full Text] [Related]
37. Plasma disposition and faecal excretion of oxfendazole, fenbendazole and albendazole following oral administration to donkeys.
Gokbulut C; Akar F; McKellar QA
Vet J; 2006 Jul; 172(1):166-72. PubMed ID: 16772142
[TBL] [Abstract][Full Text] [Related]
38. Clinical efficacy assessment of the albendazole-ivermectin combination in lambs parasitized with resistant nematodes.
Entrocasso C; Alvarez L; Manazza J; Lifschitz A; Borda B; Virkel G; Mottier L; Lanusse C
Vet Parasitol; 2008 Aug; 155(3-4):249-56. PubMed ID: 18571329
[TBL] [Abstract][Full Text] [Related]
39. LC-MS-MS identification of albendazole and flubendazole metabolites formed ex vivo by Haemonchus contortus.
Cvilink V; Skálová L; Szotáková B; Lamka J; Kostiainen R; Ketola RA
Anal Bioanal Chem; 2008 May; 391(1):337-43. PubMed ID: 18344069
[TBL] [Abstract][Full Text] [Related]
40. Effect of amphiphilic surfactant agents on the gastrointestinal absorption of albendazole in cattle.
Virkel G; Imperiale F; Lifschitz A; Pis A; Alvarez A; Merino G; Prieto J; Lanusse C
Biopharm Drug Dispos; 2003 Apr; 24(3):95-103. PubMed ID: 12673667
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
